Adhera Therapeutics, Inc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Adhera Therapeutics, Inc. payments for repurchase of common stock for the quarter ending 2022-12-31 was $0.00.
- Adhera Therapeutics, Inc. payments for repurchase of common stock for the quarter ending 2022-09-30 was $0.00.
- Adhera Therapeutics, Inc. payments for repurchase of common stock for fiscal 2022 was $2.00K.
- Adhera Therapeutics, Inc. payments for repurchase of common stock for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Adhera Therapeutics, Inc. payments for repurchase of common stock for fiscal 2018 was $250.00K.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $2.00K 10-K · filed 2023-03-31 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | |
| 2019-12-31 | $0.00 10-K · filed 2020-04-14 | |
| 2018-12-31 | $250.00K 10-K · filed 2020-04-14 |